19th Orphan Drugs & Rare Diseases Global Congress 2023 Europe

Delivering Innovative Therapies to Patients with Rare Diseases

3rd - 4th April 2023

Hilton London Kensington, London, UK

Pharma Conference London UK

19th Orphan Drugs & Rare Diseases Global Congress 2023

Paradigm Global Events is again proud to present our Orphan Drugs and Rare Diseases 2023 Europe. It’s the 19th in the series of our Flagship tri-annual Orphan Drugs and Rare Diseases event, this congress will provide you with a comprehensive overview of the critical issues shaping the future of Orphan Drugs.

The conference will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top-tier government, pharmaceuticals, biotechs, non-profit organizations, orphan drugs developers, research organizations as well as patient groups and advocates. We are putting together an agenda that address the driving macroeconomic factors, policies, and issues that will steer the development of orphan drugs globally including access, commercialization, collaborations, policies, reimbursement, pricing, and more.

The two-day Congress will provide an interactive, cutting edge, and comprehensive discussion
and networking format led by key experts with intimate knowledge in the industry. Gain
practical strategies and best practices on challenges, innovations, technologies, and
concepts surrounding orphan drugs and rare diseases.
We look forward to welcoming you to the congress!

Previous - Key Industry Experts Speakers

Doug Danison

Head of Europe, bluebird bio

Pedro Franco

Director for Global Regulatory & Scientific Policy (GRASP), Merck

Emily Crossley

Co-founder, Duchenne UK

Femida Gwadry-Sridhar

CEO and Founder, Pulse Infoframe Inc.

From a patient advocacy organization perspective, was a very informative meeting. Learned a lot from presentations and networking that will inform how we can add value to the advocacy-patient-drug developer dialogue.

Dr. Nadine Tutton

Scientific Director, Research, Association for Frontotemporal Degeneration

I was very impressed with the format, the content was interesting and well done. I felt I learned a lot and was glad to be able to attend.

Senior Director

Business Development at Pharm-Olam, LLC



Orphan Drugs & Rare Diseases Global Congress 2023 – choose your focus streams in the afternoon of both conference days by attending keynotes, presentations, and group discussions that have the most relevance to you. Choose from…

Orphan Drugs & Rare Diseases 2022 Europe


Scroll to Top